COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 571: Articles 5701-5710  | Next

The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis
Woodall, M., Cujba, A.-M., Worlock, K. B., Case, K.-M., Masonou, T., Yoshida, M., Polanski, K., Huang, N., Lindeboom, R. G., Mamanova, L., Bolt, L., Richardson, L., Ellis, S., Palor, M., Burgoyne, T., Pinto, A., Moulding, D. A., McHugh, T. D., Saleh, A., Kilich, E., Mehta, P., O'Callaghan, C., Zhou, J., Barclay, W., De Coppi, P., Butler, C. R., Vinette, H., Roy, S., Breuer, J., Chambers, R. C., Heywood, W. E., Mills, K., Hynds, R. E., Teichmann, S. A., Meyer, K. B., Nikolic, M. Z., Smith, C. M.
10.1101/2023.01.16.524211 — Posted: 2023-01-17
Enhanced transmissibility, infectivity and immune resistance of the SARS-CoV-2 Omicron XBB.1.5 variant
Uriu, K., Ito, J., Zahradnik, J., Fujita, S., Kosugi, Y., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2023.01.16.524178 — Posted: 2023-01-17
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Addetia, A., Piccoli, L., Case, J. B., Park, Y.-J., Beltramello, M., Guarino, B., Dang, H., Pinto, D., Scheaffer, S., Sprouse, K., Bassi, J., Silacci-Fregni, C., Muoio, F., Dini, M., Vincenzetti, L., Acosta, R., Johnson, D., Subramanian, S., Saliba, C., Giurdanella, M., Lombardo, G., Leoni, G., Culap, K., McAlister, C., Rajesh, A., Dellota, E., Cameroni, E., Whitener, B., Giannini, O., Ceschi, A., Ferrari, P., Franzetti-Pellanda, A., Biggiogero, M., Garzoni, C., Zappi, S., Bernasconi, L., Kim, M. J., Schnell, G., Czudnochowski, N., Franko, N., Logue, J. K., Yoshiyama, C., Stewart, C., Chu, H., Schmid, M. A., Purcell, L. A., Snell, G., Lanzavecchia, A., Diamond, M., Corti, D., Veesler, D.
10.1101/2023.01.17.523798 — Posted: 2023-01-17
Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study
Hansen, B. T., Labberton, A. S., Kour, P., Kraft, K. B.
10.1101/2023.01.13.23284467 — Posted: 2023-01-14
Occupational Determinants of COVID-19 Cumulative Incidence and Vaccination Rate in the United States
Ji, J. S., Duncan, D. T.
10.1101/2023.01.13.22274536 — Posted: 2023-01-14
SARS-CoV-2 VARIANT PREVALENCE ESTIMATION USING WASTEWATER SAMPLES
Lopez-de-Ullibarri, I., Tomas, L., Trigo-Tasende, N., Freire, B., Vaamonde, M., Gallego-Garcia, P., Barbeito, I., Vallejo, J. A., Tarrio-Saavedra, J., Alvarino, P., Beade, E., Estevez, N., Rumbo-Feal, S., Conde-Perez, K., De Chiara, L., Iglesias-Corras, I., Poza, M., Ladra, S., Posada, D., Cao, R.
10.1101/2023.01.13.23284507 — Posted: 2023-01-14
Cross-sectional Ct distributions from qPCR tests can provide an early warning signal for the spread of COVID-19 in communities
Sharmin, M., Manivannan, M., Woo, D., Sorel, O., Auclair, J., Gandhi, M., Mujawar, I.
10.1101/2023.01.12.23284489 — Posted: 2023-01-14
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders.
Denis, J., Garnier, A., Cheutin, L., Ferrier, A., Timera, H., Jarjaval, F., Hejl, C., Billon-Denis, E., Percy ImmunoCovid group, , Ricard, D., Tournier, J.-N., Trignol, A., Mura, M.
10.1101/2023.01.13.23284341 — Posted: 2023-01-14
Variations in COVID-19 impacts by social vulnerability in Philadelphia, June 2020-December 2022
Strelau, K. M., Feuerstein-Simon, R., Naseer, N., Lang, M., Rix, K., Murray, E. J., Morris, J. S., Wiebe, D. J., Nelson, H. C. M., Collman, R. G., Rodino, K. G., Bushman, F. D., Kelly, B. J., Cannuscio, C. C.
10.1101/2023.01.13.23284488 — Posted: 2023-01-14
Burden, Causation, and Particularities of long-COVID in African populations: A rapid systematic review
Nyasulu, P. S., Tamuzi, J. L., Erasmus, R. T.
10.1101/2023.01.13.23284305 — Posted: 2023-01-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).